Cargando…

Annexin A1 Preferentially Predicts Poor Prognosis of Basal-Like Breast Cancer Patients by Activating mTOR-S6 Signaling

INTRODUCTION: Annexin A1 (ANXA1) is an anti-inflammatory protein reported to play a role in cell proliferation and apoptosis, and to be deregulated in breast cancer. The exact role of annexin A1 in the biology of breast cancer remains unclear. We hypothesized that the annexin A1 plays an oncogenic r...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhardwaj, Anjana, Ganesan, Nivetha, Tachibana, Kazunoshin, Rajapakshe, Kimal, Albarracin, Constance T., Gunaratne, Preethi H., Coarfa, Cristian, Bedrosian, Isabelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4441370/
https://www.ncbi.nlm.nih.gov/pubmed/26000884
http://dx.doi.org/10.1371/journal.pone.0127678
_version_ 1782372780235292672
author Bhardwaj, Anjana
Ganesan, Nivetha
Tachibana, Kazunoshin
Rajapakshe, Kimal
Albarracin, Constance T.
Gunaratne, Preethi H.
Coarfa, Cristian
Bedrosian, Isabelle
author_facet Bhardwaj, Anjana
Ganesan, Nivetha
Tachibana, Kazunoshin
Rajapakshe, Kimal
Albarracin, Constance T.
Gunaratne, Preethi H.
Coarfa, Cristian
Bedrosian, Isabelle
author_sort Bhardwaj, Anjana
collection PubMed
description INTRODUCTION: Annexin A1 (ANXA1) is an anti-inflammatory protein reported to play a role in cell proliferation and apoptosis, and to be deregulated in breast cancer. The exact role of annexin A1 in the biology of breast cancer remains unclear. We hypothesized that the annexin A1 plays an oncogenic role in basal subtype of breast cancer by modulating key growth pathway(s). METHODS: By mining the Cancer Genome Atlas (TCGA)-Breast Cancer dataset and manipulating annexin A1 levels in breast cancer cell lines, we studied the role of annexin A1 in breast cancer and underlying signaling pathways. RESULTS: Our in-silico analysis of TCGA-breast cancer dataset demonstrated that annexin A1 mRNA expression is higher in basal subtype compared to luminal and HER2 subtypes. Within the basal subtype, patients show significantly poorer overall survival associated with higher expression of annexin A1. In both TCGA patient samples and cell lines, annexin A1 levels were significantly higher in basal-like breast cancer than luminal and Her2/neu-positive breast cancer. Stable annexin A1 knockdown in TNBC cell lines suppressed the mTOR-S6 pathway likely through activation of AMPK but had no impact on the MAPK, c-Met, and EGFR pathways. In a cell migration assay, annexin A1-depleted TNBC cells showed delayed migration as compared to wild-type cells, which could be responsible for poor patient prognosis in basal like breast cancers that are known to express higher annexin A1. CONCLUSIONS: Our data suggest that annexin A1 is prognostic only in patients with basal like breast cancer. This appears to be in part due to the role of annexin A1 in activating mTOR-pS6 pathway.
format Online
Article
Text
id pubmed-4441370
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-44413702015-05-28 Annexin A1 Preferentially Predicts Poor Prognosis of Basal-Like Breast Cancer Patients by Activating mTOR-S6 Signaling Bhardwaj, Anjana Ganesan, Nivetha Tachibana, Kazunoshin Rajapakshe, Kimal Albarracin, Constance T. Gunaratne, Preethi H. Coarfa, Cristian Bedrosian, Isabelle PLoS One Research Article INTRODUCTION: Annexin A1 (ANXA1) is an anti-inflammatory protein reported to play a role in cell proliferation and apoptosis, and to be deregulated in breast cancer. The exact role of annexin A1 in the biology of breast cancer remains unclear. We hypothesized that the annexin A1 plays an oncogenic role in basal subtype of breast cancer by modulating key growth pathway(s). METHODS: By mining the Cancer Genome Atlas (TCGA)-Breast Cancer dataset and manipulating annexin A1 levels in breast cancer cell lines, we studied the role of annexin A1 in breast cancer and underlying signaling pathways. RESULTS: Our in-silico analysis of TCGA-breast cancer dataset demonstrated that annexin A1 mRNA expression is higher in basal subtype compared to luminal and HER2 subtypes. Within the basal subtype, patients show significantly poorer overall survival associated with higher expression of annexin A1. In both TCGA patient samples and cell lines, annexin A1 levels were significantly higher in basal-like breast cancer than luminal and Her2/neu-positive breast cancer. Stable annexin A1 knockdown in TNBC cell lines suppressed the mTOR-S6 pathway likely through activation of AMPK but had no impact on the MAPK, c-Met, and EGFR pathways. In a cell migration assay, annexin A1-depleted TNBC cells showed delayed migration as compared to wild-type cells, which could be responsible for poor patient prognosis in basal like breast cancers that are known to express higher annexin A1. CONCLUSIONS: Our data suggest that annexin A1 is prognostic only in patients with basal like breast cancer. This appears to be in part due to the role of annexin A1 in activating mTOR-pS6 pathway. Public Library of Science 2015-05-22 /pmc/articles/PMC4441370/ /pubmed/26000884 http://dx.doi.org/10.1371/journal.pone.0127678 Text en © 2015 Bhardwaj et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Bhardwaj, Anjana
Ganesan, Nivetha
Tachibana, Kazunoshin
Rajapakshe, Kimal
Albarracin, Constance T.
Gunaratne, Preethi H.
Coarfa, Cristian
Bedrosian, Isabelle
Annexin A1 Preferentially Predicts Poor Prognosis of Basal-Like Breast Cancer Patients by Activating mTOR-S6 Signaling
title Annexin A1 Preferentially Predicts Poor Prognosis of Basal-Like Breast Cancer Patients by Activating mTOR-S6 Signaling
title_full Annexin A1 Preferentially Predicts Poor Prognosis of Basal-Like Breast Cancer Patients by Activating mTOR-S6 Signaling
title_fullStr Annexin A1 Preferentially Predicts Poor Prognosis of Basal-Like Breast Cancer Patients by Activating mTOR-S6 Signaling
title_full_unstemmed Annexin A1 Preferentially Predicts Poor Prognosis of Basal-Like Breast Cancer Patients by Activating mTOR-S6 Signaling
title_short Annexin A1 Preferentially Predicts Poor Prognosis of Basal-Like Breast Cancer Patients by Activating mTOR-S6 Signaling
title_sort annexin a1 preferentially predicts poor prognosis of basal-like breast cancer patients by activating mtor-s6 signaling
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4441370/
https://www.ncbi.nlm.nih.gov/pubmed/26000884
http://dx.doi.org/10.1371/journal.pone.0127678
work_keys_str_mv AT bhardwajanjana annexina1preferentiallypredictspoorprognosisofbasallikebreastcancerpatientsbyactivatingmtors6signaling
AT ganesannivetha annexina1preferentiallypredictspoorprognosisofbasallikebreastcancerpatientsbyactivatingmtors6signaling
AT tachibanakazunoshin annexina1preferentiallypredictspoorprognosisofbasallikebreastcancerpatientsbyactivatingmtors6signaling
AT rajapakshekimal annexina1preferentiallypredictspoorprognosisofbasallikebreastcancerpatientsbyactivatingmtors6signaling
AT albarracinconstancet annexina1preferentiallypredictspoorprognosisofbasallikebreastcancerpatientsbyactivatingmtors6signaling
AT gunaratnepreethih annexina1preferentiallypredictspoorprognosisofbasallikebreastcancerpatientsbyactivatingmtors6signaling
AT coarfacristian annexina1preferentiallypredictspoorprognosisofbasallikebreastcancerpatientsbyactivatingmtors6signaling
AT bedrosianisabelle annexina1preferentiallypredictspoorprognosisofbasallikebreastcancerpatientsbyactivatingmtors6signaling